Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples.

Mankor, Joanne M; Paats, Marthe S; Groenendijk, Floris H; Roepman, Paul; Dinjens, Winand N M; Dubbink, Hendrikus J; Sleijfer, Stefan; Cuppen, Edwin; Lolkema, Martijn P J K

Mankor, Joanne M; Paats, Marthe S; Groenendijk, Floris H; Roepman, Paul; Dinjens, Winand N M; Dubbink, Hendrikus J; Sleijfer, Stefan; Cuppen, Edwin; Lolkema, Martijn P J K.

Afiliação

Mankor JM; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands.
Paats MS; Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands. m.paats@erasmusmc.nl.
Groenendijk FH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.
Dinjens WNM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Dubbink HJ; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Lolkema MPJK; Hartwig Medical Foundation, Amsterdam, The Netherlands.

Br J Cancer ; 122(7): 953-956, 2020 03.

Article em En | MEDLINE | ID: mdl-32094484

Assuntos

Biomarcadores Tumorais/metabolismo; Neoplasias/genética; Carga Tumoral/genética; Humanos; Metástase Neoplásica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carga Tumoral / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google